Cargando…

The immunological footprint of CMV in HIV-1 patients stable on long-term ART

BACKGROUND: Most HIV-infected persons are cytomegalovirus (CMV) seropositive and retain latent virus that can be reactivated by immune activation. Their T cell populations express markers reflecting a late stage of differentiation, but the contributions of HIV and CMV to this profile are unclear. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Affandi, Jacquita S., Montgomery, Jacinta, Brunt, Samantha J., Nolan, David, Price, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591633/ https://www.ncbi.nlm.nih.gov/pubmed/26435726 http://dx.doi.org/10.1186/s12979-015-0041-0

Ejemplares similares

HIV patients stable on ART retain evidence of a high CMV load but changes to Natural Killer cell phenotypes reflect both HIV and CMV
por: Affandi, Jacquita S., et al.
Publicado: (2015)

The Search for a Genetic Factor Associating with Immune Restoration Disease in HIV Patients Co-Infected with Mycobacterium tuberculosis
por: Affandi, Jacquita S., et al.
Publicado: (2013)

The Use of Humoral Responses as a Marker of CMV Burden in HIV Patients on ART Requires Consideration of T-Cell Recovery and Persistent B-Cell Activation
por: Brunt, Samantha J., et al.
Publicado: (2014)

Immunological diagnosis of CMV infection in HIV-infected patients
por: Dumitru, IM, et al.
Publicado: (2010)

The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV
por: Carbone, Javier
Publicado: (2016)

Sex Differences in CMV Replication and HIV Persistence During Suppressive ART
por: Gianella, Sara, et al.
Publicado: (2020)

A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population
por: Lee, Silvia, et al.
Publicado: (2019)

Which NK cell populations mark the high burden of CMV present in all HIV patients beginning ART in Indonesia?
por: Ariyanto, Ibnu A., et al.
Publicado: (2022)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
por: Barnes, Samantha, et al.
Publicado: (2020)

The Detection of CMV in Saliva Can Mark a Systemic Infection with CMV in Renal Transplant Recipients
por: Waters, Shelley, et al.
Publicado: (2019)

Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?
por: Krastinova, Evguenia, et al.
Publicado: (2015)

A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART
por: Ujeneza, Eva Liliane, et al.
Publicado: (2021)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1–Infected Individuals
por: Aichelburg, Maximilian C., et al.
Publicado: (2015)

Long-term CMV monitoring and chronic rejection in renal transplant recipients
por: Ishikawa, Shoko, et al.
Publicado: (2023)

P16-48. Immunologic and virologic characterization of an ART-treated HIV-1 patients cohort with long-term control of viremia
por: Kinloch, S, et al.
Publicado: (2009)

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine
por: Guan, Min, et al.
Publicado: (2022)

Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies
por: Han, Sang Hoon
Publicado: (2017)

CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire
por: Hassan, Norfarazieda, et al.
Publicado: (2022)

S291: LONG-TERM SAFETY AND EFFICACY OF CMV/EBV-SPECIFIC T CELLS FOR CMV AND EBV CO-REACTIVATION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION
por: Xuying, Pei, et al.
Publicado: (2023)

COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023)

Bioinformatics in molecular immunology laboratories demonstrated: Modeling an anti-CMV scFv antibody
por: Heng, Chua Kek, et al.
Publicado: (2006)

Immunological age prediction in HIV-infected, ART-treated individuals
por: de Armas, Lesley R., et al.
Publicado: (2021)

Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART
por: Dan, Jennifer M., et al.
Publicado: (2016)

Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls
por: Booiman, Thijs, et al.
Publicado: (2017)

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation
por: Park, Ga Eun, et al.
Publicado: (2021)

The Water Footprint of Hydropower Production—State of the Art and Methodological Challenges
por: Bakken, Tor Haakon, et al.
Publicado: (2017)

CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection – a retrospective autopsy based study
por: Brantsaeter, Arne B, et al.
Publicado: (2007)

The TLR9 2848C/T Polymorphism Is Associated with the CMV DNAemia among HIV/CMV Co-Infected Patients
por: Jabłońska, Agnieszka, et al.
Publicado: (2021)

A rare case of CMV pneumonia in HIV-infection
por: Poh, Kai Chin, et al.
Publicado: (2019)

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Effects of Aging, Long-Term and Lifelong Exercise on the Urinary Metabolic Footprint of Rats
por: Tzimou, Anastasia, et al.
Publicado: (2020)

1551. The Impact of Recurrent CMV Disease on Long-Term Survival in Solid Organ Transplant Recipients
por: Gardiner, Bradley, et al.
Publicado: (2018)

CMV-Responsive CD4 T Cells Have a Stable Cytotoxic Phenotype Over the First Year Post-Transplant in Patients Without Evidence of CMV Viremia
por: Higdon, Lauren E., et al.
Publicado: (2022)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

CMV and EBV Co-Infection in HIV-Infected Children: Infection Rates and Analysis of Differential Expression of Cytokines in HIV Mono- and HIV–CMV–EBV Co-Infected Groups
por: Nazim, Fizza, et al.
Publicado: (2022)

940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
por: Khawaja, Fareed, et al.
Publicado: (2021)

Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients
por: Seo, Euri, et al.
Publicado: (2021)

Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection
por: Andrieu, Jean-Marie, et al.
Publicado: (2004)

The Impact of a CMV Infection on the Expression of Selected Immunological Parameters in Liver Tissue in Children with Biliary Atresia
por: Janowska, Maria, et al.
Publicado: (2022)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2s5r9oiojk62k0cpl40m2fpgc3